OverviewChartNewsTraderScreen

BVT Knock-Out BAYN 21.03.2025/  DE000VC40W56  /

EUWAX
1/10/2025  5:37:03 PM Chg.-0.02 Bid5:45:53 PM Ask5:45:53 PM Underlying Strike price Expiration date Option type
1.41EUR -1.40% 1.40
Bid Size: 80,000		 1.41
Ask Size: 80,000		 BAYER AG NA O.N. 34.20 EUR 3/21/2025 Put
TeleTrader 11/12/2024 Bayer dips 12%, hits 20-year low after earnings report
TeleTrader 11/12/2024 Bayer's sales in Q3 down 3.6% to €9.9 billion
TeleTrader 8/16/2024 Bayer jumps 10% after Roundup court win
GlobeNewswire 8/2/2024 Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting A...
GlobeNewswire 7/11/2024 AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational...
GlobeNewswire 6/25/2024 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 5/30/2024 Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire 5/30/2024 BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire 5/29/2024 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 5/28/2024 Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement
TeleTrader 5/14/2024 Bayer's sales in Q1 at €13.7 billion, down 4.3%
GlobeNewswire 5/2/2024 AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire 4/18/2024 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire 4/16/2024 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire 4/11/2024 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire 4/9/2024 AskBio Names Mansuo Shannon Chief Scientific Officer
GlobeNewswire 3/25/2024 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire 3/14/2024 Bayer and Aignostics to collaborate on next generation precision oncology
GlobeNewswire 3/6/2024 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
TeleTrader 3/5/2024 Bayer's Q4 sales at €11.9 billion
GlobeNewswire 3/4/2024 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
TeleTrader 3/4/2024 Earnings preview: Bayer, Broadcom among those in calendar
GlobeNewswire 2/15/2024 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire 2/13/2024 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire 2/13/2024 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure